# A Study to Evaluate Withdrawal Effects Following Dosing of Oxycodone/Naltrexone in Methadone-Maintained Subjects

> **NCT02391571** · PHASE3 · COMPLETED · sponsor: **Elite Laboratories, Inc** · enrollment: 26 (actual)

## Conditions studied

- Withdrawal Symptoms

## Interventions

- **DRUG:** Oxycodone/Naltrexone Capsules
- **DRUG:** Oxycodone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02391571
- **Lead sponsor:** Elite Laboratories, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2016-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02391571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02391571, "A Study to Evaluate Withdrawal Effects Following Dosing of Oxycodone/Naltrexone in Methadone-Maintained Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02391571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*